MORC2 and Charcot-Marie-Tooth disease: Specifically, MORC2 S87L, a mutation associated with Charcot–Marie–Tooth disease (CMT) stabilizes GHKL dimerization and has negligible ATPase activity and high levels of silencing in cells.